IMP3 Protein Overexpression Is Linked to Unfavorable Outcome in Laryngeal Squamous Cell Carcinoma
Authors:
Open Access
Abstract
Background: The aim of this study was to (i) determine IMP3 protein expression in benign and malignant laryngeal lesions, (ii) compare its expression to Ki-67, p53, cyclin D1, and (iii) finally, to examine the prognostic power of IMP3 in squamous cell carcinomas of the larynx (LSSC). Methods: IMP3 protein expression was evaluated in 145 patients, including 62 LSCC, 45 dysplasia (25 with low and 20 with high-grade dysplasia), and 38 benign lesions (vocal cord polyps and nodules). Results: IMP3 was significantly higher expressed in LSCC compared to dysplasia and benign lesions (p < 0.001; p < 0.001, respectively). Similarly, higher expression patterns were observed for Ki-67 and p53, whereas cyclin D1 was equally distributed in all three lesions. IMP3 (p = 0.04) and Ki-67 (p = 0.02) expressions were significantly linked to neck node positivity, and IMP3 overexpression to worse disease-specific survival (p = 0.027). Conclusion: Since IMP3 showed significantly higher expression in laryngeal carcinomas, but not in high- or low-grade dysplasia, it serves as a useful marker to differentiate between invasive and noninvasive lesions. Higher IMP3 expression represented a significantly worse prognosticator for clinical outcomes of patients with squamous cell carcinoma of the larynx.Keywords
This publication has 33 references indexed in Scilit:
- IMP3 Immunoreactivity is More Sensitive Than AMACR in Detecting Dysplastic Epithelium and Early Adenocarcinoma in Barrett EsophagusApplied Immunohistochemistry & Molecular Morphology, 2017
- Effect of postoperative use of diclofenac on pharyngocutaneous fistula development after primary total laryngopharyngectomy: Results of a single‐center retrospective studyHead & Neck, 2015
- Imp3 Expression in Benign and Malignant Thyroid Tumors and Hyperplastic NodulesBalkan Medical Journal, 2015
- Expression and clinical significance of IMP3 in microdissected premalignant and malignant pancreatic lesionsClinical and Translational Oncology, 2014
- Oncofetal Protein IMP3, a New Cancer BiomarkerAdvances in Anatomic Pathology, 2014
- The oncofetal protein IMP3: a novel biomarker and triage tool for premalignant atypical endometriotic lesionsFertility and Sterility, 2013
- An expanding role for cell biologists in drug discovery and pharmacologyMolecular Biology of the Cell, 2012
- Identification of novel target proteins in sebaceous gland carcinomaHead & Neck, 2012
- Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective studyThe Lancet Oncology, 2006
- Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing proteinOncogene, 1997